Xenon Joins the Russell 3000® and Russell 2000® Indexes
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon Announces Appointment of Darren Cline as Chief Commercial Officer
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference